市場調査レポート

商品コード

1434237

急性腎障害治療市場：製品タイプ、障害タイプ、エンドユーザー別-2024-2030年の世界予測

Acute Kidney Injury Treatment Market (AKI) by Product (Dialysis, Drug Therapy), Injury Type (Intrinsic-Renal Acute Kidney Injury, Post-Renal Acute Kidney Injury, Pre-Renal Acute Kidney Injury), End-User - Global Forecast 2024-2030

出版日: 2024年01月15日 | 発行: 360iResearch

| ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 743,598円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 900,178円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,056,758円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,369,918円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.58円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

急性腎障害治療市場規模は2023年に18億7,000万米ドルと推計され、2024年には20億2,000万米ドルに達し、CAGR 7.81%で2030年には31億7,000万米ドルに達すると予測されます。

急性腎障害治療の世界市場

主な市場の統計
基準年[2023］	18億7,000万米ドル
予測年[2024］	20億2,000万米ドル
予測年 [2030]	31億7,000万米ドル
CAGR（%）	7.81%

急性腎障害（AKI）治療とは、急性腎障害（突然の腎障害や腎不全）に罹患した患者の管理と回復のための治療ソリューション、機器、サービスの提供を指します。治療の選択肢には、正常な腎機能の回復とさらなる合併症の予防を目的とした、さまざまな医薬品、透析機器、高度な治療法、支持療法サービスが含まれます。AKI治療の適用範囲は、病院、集中治療室（ICU）、腎臓内科クリニック、在宅ヘルスケアなど、さまざまな臨床現場に及んでいます。AKIにつながる病態の有病率の増加や、AKIに対して脆弱な高齢者人口の増加により、早急な治療ソリューションの展開が必要とされています。さらに、診断ツールや治療法の技術的進歩、ヘルスケア支出の増加により、治療サービスの提供が拡大しています。しかし、治療オプションに対する払い戻しがなく、AKIの治療を受けるには高額な費用がかかるため、治療オプションへのアクセスが制限される可能性があります。承認に時間がかかり、新製品の商業化が遅れることにつながる厳しい規制政策も懸念材料です。しかし、メーカーやバイオテクノロジー企業は、規制当局の承認プロセスを緩和するための選択肢を模索しています。この分野で事業を展開する企業にとって、技術革新に焦点を当てた研究開発に投資することは極めて重要です。

地域別の洞察

南北アメリカでは、米国が、腎臓病のリスクが高まる高齢化社会に対応する高度な技術革新に関連しています。南北アメリカ地域の特徴は、AKI治療の選択肢を拡大するための政府の取り組みが存在することです。欧州連合（EU）は、国民の間でCKDが増加しているため、新規AKI治療に対する一貫したニーズがあります。ドイツ、フランス、英国を含む欧州諸国には、常に革新的で斬新な治療法を模索している強力なバイオテクノロジー企業や製薬企業があります。中国、日本、インドは人口が多く、腎臓関連疾患の有病率が増加しているため、AKI治療に対するニーズが高いです。中国政府は医療アクセスを強化するためのイニシアチブをいくつか打ち出しており、これがAKI治療に対する需要を押し上げると期待されています。日本もまた、急速な高齢化と高度なヘルスケアインフラにより、大きな市場ポテンシャルを有しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、急性腎障害治療市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、急性腎障害治療市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-急性腎障害治療市場の市場規模および予測は？

2-急性腎障害治療市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-急性腎障害治療市場における技術動向と規制の枠組みは？

4-急性腎障害治療市場における主要ベンダーの市場シェアは？

5-急性腎障害治療市場への参入に適した形態や戦略的手段は？

市場力学
- 促進要因
  - 腎不全と腎臓関連疾患の増加
  - 腎疾患治療薬の承認数が増加
  - 腎臓の健康に対する意識を高める政府の取り組み
- 抑制要因
  - 高額な治療費と払い戻しの欠如
- 機会
  - 腎臓治療の選択肢を強化し、病気の検出を改善するための進歩
  - 腎臓治療を提供する病院の新設と外来診療の改善
- 課題
  - 特定の腎損傷治療オプションに関する厳しい規制
市場セグメンテーション分析
- 製品：透析治療を改善するための調査イニシアチブの増加
- 損傷の種類：腎損傷の根本的な原因についての認識が、内因性腎性急性腎損傷の治療法の開発につながります。
- エンドユーザー：外来診療の改善により、外来手術センター（ASC）の普及率が上昇
市場動向分析
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み

第6章急性腎障害治療市場：製品別

透析
- 継続的腎代替療法（CRRT）
- 間欠的血液透析
- 持続的低効率透析（SLED）
薬物セラピー
- 抗生物質
- 利尿薬
- 免疫抑制剤

第7章急性腎障害治療市場怪我の種類別

内因性腎性急性腎障害
腎損傷後の急性腎損傷
腎前性急性腎損傷

第8章急性腎障害治療市場：エンドユーザー別

外来手術センター
病院

第9章南北アメリカの急性腎障害治療市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第10章アジア太平洋地域の急性腎障害治療市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第11章欧州・中東・アフリカの急性腎障害治療市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第12章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ主要企業別の分析
- 合併・買収
- 受賞・表彰・拡大

第13章競争力のあるポートフォリオ

主要な企業プロファイル
- Abbott Laboratories
- Alloksys Life Sciences B.V.
- Amgen Inc.
- Angion Biomedica Corp.
- Asahi Kasei Medical Co., Ltd.
- B. Braun Melsungen AG
- Baxter International, Inc.
- Bayer AG
- bioMerieux SA
- Dr. Reddys Laboratories Ltd.
- Fresenius Medical Care AG & Co. KGaA
- GlaxoSmithKline PLC
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novartis AG
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.
- Reata Pharmaceuticals Inc. by Biogen Inc.
- Rockwell Medical, Inc.
- Silver Creek Pharmaceuticals, Inc.
- Stealth BioTherapeutics, Inc.
- Teva Pharmaceutical Industries Ltd.
主要な製品ポートフォリオ

第14章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. ACUTE KIDNEY INJURY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ACUTE KIDNEY INJURY TREATMENT MARKET DYNAMICS
FIGURE 7. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2023 VS 2030 (%)
FIGURE 10. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ACUTE KIDNEY INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ACUTE KIDNEY INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

TABLE 1. ACUTE KIDNEY INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 8. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY SUSTAINED LOW-EFFICIENCY DIALYSIS (SLED), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 13. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 17. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INTRINSIC-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY POST-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRE-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 41. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 42. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 46. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 47. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 68. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 69. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 70. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 73. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 74. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 83. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 84. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 113. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 114. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 129. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 134. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 135. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 139. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 140. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 144. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 145. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 150. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 159. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 160. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 174. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 175. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 179. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 180. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 181. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 184. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 185. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 204. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 205. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 219. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 220. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. ACUTE KIDNEY INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 233. ACUTE KIDNEY INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 234. ACUTE KIDNEY INJURY TREATMENT MARKET LICENSE & PRICING

Product Code: MRR-035DA3C63708

[186 Pages Report] The Acute Kidney Injury Treatment Market size was estimated at USD 1.87 billion in 2023 and expected to reach USD 2.02 billion in 2024, at a CAGR 7.81% to reach USD 3.17 billion by 2030.

Global Acute Kidney Injury Treatment Market

KEY MARKET STATISTICS
Base Year [2023]	USD 1.87 billion
Estimated Year [2024]	USD 2.02 billion
Forecast Year [2030]	USD 3.17 billion
CAGR (%)	7.81%

Acute Kidney Injury Treatment Market - IMG1

Acute kidney injury (AKI) treatment refers to the provision of therapeutic solutions, devices, and services for the management and recovery of patients suffering from acute kidney injury, a sudden case of kidney damage or failure. Treatment options include various pharmaceutical drugs, dialysis equipment, advanced treatment modalities, and supportive care services aimed at restoring normal kidney function and preventing further complications. The application of AKI treatment encompasses various clinical settings such as hospitals, intensive care units (ICUs), nephrology clinics, and home healthcare. The increasing prevalence of conditions leading to AKI and a growing elderly population vulnerable to AKI have necessitated the deployment of immediate treatment solutions. Additionally, technological advancements in diagnostic tools, therapies and rising healthcare expenditure have expanded the provision of treatment services. However, the lack of reimbursements for treatment options and the high cost of availing treatment for AKI may limit the accessibility of treatment options. Stringent regulatory policies leading to longer approval times and delayed commercialization of new products also pose concerns. However, manufacturers and biotechnological companies are exploring options to ease the regulatory approval process. It is crucial for businesses operating in this segment to invest in research and development with a focus on innovation.

Regional Insights

In the Americas, the United States is associated with advanced technological innovations that cater to the aging population with an increased risk of kidney diseases. The Americas region is characterized by the presence of government initiatives to expand AKI treatment options. The European Union witnesses a consistent need for novel AKI treatments due to increasing occurrences of CKD among its citizens. European nations, including Germany, France, and the UK, have robust biotechnology and pharmaceutical companies that are constantly innovating and exploring novel treatment options. China, Japan, and India have a significant need for AKI treatment owing to their large population base and increasing prevalence of kidney-related disorders. The Chinese government has launched several initiatives to enhance healthcare access, which, in turn, is expected to boost the demand for AKI treatments. Japan also exhibits a significant market potential due to its rapidly aging population and advanced healthcare infrastructure.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Acute Kidney Injury Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acute Kidney Injury Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Acute Kidney Injury Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alloksys Life Sciences B.V., Amgen Inc., Angion Biomedica Corp., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Bayer AG, bioMerieux SA, Dr. Reddys Laboratories Ltd., Fresenius Medical Care AG & Co. KGaA, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Reata Pharmaceuticals Inc. by Biogen Inc., Rockwell Medical, Inc., Silver Creek Pharmaceuticals, Inc., Stealth BioTherapeutics, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Acute Kidney Injury Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Dialysis
  - Continuous Renal Replacement Therapy (CRRT)
  - Intermittent Hemodialysis
  - Sustained Low-Efficiency Dialysis (SLED)
- Drug Therapy
  - Antibiotics
  - Diuretics
  - Immunosuppressive Agents
Injury Type
- Intrinsic-Renal Acute Kidney Injury
- Post-Renal Acute Kidney Injury
- Pre-Renal Acute Kidney Injury
End-User
- Ambulatory Surgical Centers
- Hospitals
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Acute Kidney Injury Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acute Kidney Injury Treatment Market?

3. What are the technology trends and regulatory frameworks in the Acute Kidney Injury Treatment Market?

4. What is the market share of the leading vendors in the Acute Kidney Injury Treatment Market?

5. Which modes and strategic moves are suitable for entering the Acute Kidney Injury Treatment Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Acute Kidney Injury Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising number of kidney failures and kidney-related diseases
  - 5.1.1.2. Growing number of drug approvals for the treatment of kidney disorders
  - 5.1.1.3. Government initiatives to raise awareness about kidney health
- 5.1.2. Restraints
  - 5.1.2.1. High cost of availing treatment and lack of reimbursements
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements to enhance kidney treatment options and improve disease detection
  - 5.1.3.2. New hospitals providing kidney treatment and improvements in outpatient care
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulations concerning certain kidney injury treatment options
5.2. Market Segmentation Analysis
- 5.2.1. Product: Rising number of research initiatives to improve dialysis treatment
- 5.2.2. Injury type: Awareness about underlying causes of kidney injury leading to the creation of treatments for Intrinsic-Renal Acute Kidney Injury
- 5.2.3. End-user: Improvements in outpatient care leading to rising prevalence of ambulatory surgical centers (ASCs)
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Acute Kidney Injury Treatment Market, by Product

6.1. Introduction
6.2. Dialysis
- 6.3.1. Continuous Renal Replacement Therapy (CRRT)
- 6.3.2. Intermittent Hemodialysis
- 6.3.3. Sustained Low-Efficiency Dialysis (SLED)
6.3. Drug Therapy
- 6.4.1. Antibiotics
- 6.4.2. Diuretics
- 6.4.3. Immunosuppressive Agents

7. Acute Kidney Injury Treatment Market, by Injury Type

7.1. Introduction
7.2. Intrinsic-Renal Acute Kidney Injury
7.3. Post-Renal Acute Kidney Injury
7.4. Pre-Renal Acute Kidney Injury

8. Acute Kidney Injury Treatment Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals

9. Americas Acute Kidney Injury Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Acute Kidney Injury Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Acute Kidney Injury Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Merger & Acquisition
  - 12.3.1.1. Novartis to Buy Chinook for Up to USD 3.5 Billion, Expanding Kidney Disease Pipeline
  - 12.3.1.2. CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
- 12.3.2. Award, Recognition, & Expansion
  - 12.3.2.1. SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Alloksys Life Sciences B.V.
- 13.1.3. Amgen Inc.
- 13.1.4. Angion Biomedica Corp.
- 13.1.5. Asahi Kasei Medical Co., Ltd.
- 13.1.6. B. Braun Melsungen AG
- 13.1.7. Baxter International, Inc.
- 13.1.8. Bayer AG
- 13.1.9. bioMerieux SA
- 13.1.10. Dr. Reddys Laboratories Ltd.
- 13.1.11. Fresenius Medical Care AG & Co. KGaA
- 13.1.12. GlaxoSmithKline PLC
- 13.1.13. Johnson & Johnson Services, Inc.
- 13.1.14. Merck & Co., Inc.
- 13.1.15. Novartis AG
- 13.1.16. Otsuka Pharmaceutical Co., Ltd.
- 13.1.17. Pfizer Inc.
- 13.1.18. Reata Pharmaceuticals Inc. by Biogen Inc.
- 13.1.19. Rockwell Medical, Inc.
- 13.1.20. Silver Creek Pharmaceuticals, Inc.
- 13.1.21. Stealth BioTherapeutics, Inc.
- 13.1.22. Teva Pharmaceutical Industries Ltd.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

急性腎障害治療市場：製品タイプ、障害タイプ、エンドユーザー別-2024-2030年の世界予測

Acute Kidney Injury Treatment Market (AKI) by Product (Dialysis, Drug Therapy), Injury Type (Intrinsic-Renal Acute Kidney Injury, Post-Renal Acute Kidney Injury, Pre-Renal Acute Kidney Injury), End-User - Global Forecast 2024-2030

本レポートは、以下の側面に関する貴重な洞察を提供しています：

本レポートは、以下のような主要な質問に対応しています：

目次

第1章序文

第2章調査手法

第3章エグゼクティブサマリー

第4章市場の概要

第5章市場洞察

第6章急性腎障害治療市場：製品別

第7章急性腎障害治療市場怪我の種類別

第8章急性腎障害治療市場：エンドユーザー別

第9章南北アメリカの急性腎障害治療市場

第10章アジア太平洋地域の急性腎障害治療市場

第11章欧州・中東・アフリカの急性腎障害治療市場

第12章競合情勢

第13章競争力のあるポートフォリオ

第14章付録

LIST OF FIGURES

LIST OF TABLES

This research report categorizes the Acute Kidney Injury Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Acute Kidney Injury Treatment Market, by Product

7. Acute Kidney Injury Treatment Market, by Injury Type

8. Acute Kidney Injury Treatment Market, by End-User

9. Americas Acute Kidney Injury Treatment Market

10. Asia-Pacific Acute Kidney Injury Treatment Market

11. Europe, Middle East & Africa Acute Kidney Injury Treatment Market

12. Competitive Landscape

13. Competitive Portfolio

14. Appendix

急性腎障害治療市場：製品タイプ、障害タイプ、エンドユーザー別-2024-2030年の世界予測

Acute Kidney Injury Treatment Market (AKI) by Product (Dialysis, Drug Therapy), Injury Type (Intrinsic-Renal Acute Kidney Injury, Post-Renal Acute Kidney Injury, Pre-Renal Acute Kidney Injury), End-User - Global Forecast 2024-2030

本レポートは、以下の側面に関する貴重な洞察を提供しています：

本レポートは、以下のような主要な質問に対応しています：

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 急性腎障害治療市場：製品別

第7章 急性腎障害治療市場怪我の種類別

第8章 急性腎障害治療市場：エンドユーザー別

第9章 南北アメリカの急性腎障害治療市場

第10章 アジア太平洋地域の急性腎障害治療市場

第11章 欧州・中東・アフリカの急性腎障害治療市場

第12章 競合情勢

第13章 競争力のあるポートフォリオ

第14章 付録

LIST OF FIGURES

LIST OF TABLES

This research report categorizes the Acute Kidney Injury Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Acute Kidney Injury Treatment Market, by Product

7. Acute Kidney Injury Treatment Market, by Injury Type

8. Acute Kidney Injury Treatment Market, by End-User

9. Americas Acute Kidney Injury Treatment Market

10. Asia-Pacific Acute Kidney Injury Treatment Market

11. Europe, Middle East & Africa Acute Kidney Injury Treatment Market

12. Competitive Landscape

13. Competitive Portfolio

14. Appendix

第1章序文

第2章調査手法

第3章エグゼクティブサマリー

第4章市場の概要

第5章市場洞察

第6章急性腎障害治療市場：製品別

第7章急性腎障害治療市場怪我の種類別

第8章急性腎障害治療市場：エンドユーザー別

第9章南北アメリカの急性腎障害治療市場

第10章アジア太平洋地域の急性腎障害治療市場

第11章欧州・中東・アフリカの急性腎障害治療市場

第12章競合情勢

第13章競争力のあるポートフォリオ

第14章付録